BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 29518976)

  • 1. EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.
    Dojcinov SD; Fend F; Quintanilla-Martinez L
    Pathogens; 2018 Mar; 7(1):. PubMed ID: 29518976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
    Quintanilla-Martinez L; Swerdlow SH; Tousseyn T; Barrionuevo C; Nakamura S; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):227-244. PubMed ID: 36216980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.
    Kim WY; Montes-Mojarro IA; Fend F; Quintanilla-Martinez L
    Front Pediatr; 2019; 7():71. PubMed ID: 30931288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
    Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus-associated Lymphoproliferative Disorders in the Skin.
    Goodlad JR
    Surg Pathol Clin; 2017 Jun; 10(2):429-453. PubMed ID: 28477890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S; Ko YH
    J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS; Oon ML; Wang S; Tan SY; Ng SB
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
    Schwartz Z; Bowe RB; Coleman M; Magro CM
    Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features.
    Syrykh C; PƩricart S; Lamaison C; EscudiƩ F; Brousset P; Laurent C
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous EBV-related lymphoproliferative disorders.
    Gru AA; Jaffe ES
    Semin Diagn Pathol; 2017 Jan; 34(1):60-75. PubMed ID: 27988064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranodal NK/T cell lymphoma and lymphomatoid granulomatosis in a patient with chronic lymphocytic leukaemia: Case report for a new perspective on Richter syndrome.
    Abi-Rafeh J; Beamish IV; Haegert DG; Cournoyer D; Michel RP
    Medicine (Baltimore); 2020 May; 99(19):e20106. PubMed ID: 32384485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop.
    Climent F; Nicolae A; de Leval L; Dirnhofer S; Leoncini L; Ondrejka SL; Soma L; Wotherspoon A; Zamo A; Quintanilla-Martinez L; Ng SB
    Virchows Arch; 2023 Sep; 483(3):333-348. PubMed ID: 37646869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
    Bienemann K; Borkhardt A; Klapper W; Oschlies I
    Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related EBV-associated B-cell lymphoproliferative disorders and other EBV + lymphoproliferative diseases: New insights into immune escape and immunodeficiency through staining with anti-PD-L1 antibody clone SP142.
    Sakakibara A; Kohno K; Ishikawa E; Suzuki Y; Shimada S; Eladl AE; Elsayed AA; Daroontum T; Satou A; Takahara T; Ohashi A; Takahashi E; Kato S; Nakamura S; Asano N
    Pathol Int; 2020 Aug; 70(8):481-492. PubMed ID: 32367595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting.
    Cohen JI; Iwatsuki K; Ko YH; Kimura H; Manoli I; Ohshima K; Pittaluga S; Quintanilla-Martinez L; Jaffe ES
    Leuk Lymphoma; 2020 Apr; 61(4):808-819. PubMed ID: 31833428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ hybridisation for Epstein-Barr virus as a differential diagnostic tool for T- and natural killer/T-cell lymphomas in non-immunocompromised patients.
    Chuang SS
    Pathology; 2014 Dec; 46(7):581-91. PubMed ID: 25393247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.